A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib

Saved in:
Bibliographic Details
Main Authors: Mary Clark, MD (Author), Paul Imbriano, DO (Author), Michael Harwood, MD (Author), Klaus Busam, MD (Author), Leslie Robinson-Bostom, MD (Author)
Format: Book
Published: Elsevier, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Item Description:2352-5126
10.1016/j.jdcr.2022.03.006